Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

313 results about "Personalized medicine" patented technology

Personalized medicine, precision medicine, or theranostics is a medical model that separates people into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease. The terms personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept though some authors and organisations use these expressions separately to indicate particular nuances.

Systems and methods to deliver a personalized mediacast with an uninterrupted lead-in portion

Content delivery is provided responsive to mediacast content consumer requests by providing personalized mediacasts to each of a plurality of mediacast content consumers. Each of the personalized mediacasts includes a variety of replaceable programming and non-programming content segments and a variety of non-replaceable programming and non-programming content segments. Replacement programming and non-programming content segments may be targeted, for example selected based in part on one or more selection criterion associated with the mediacast content consumer, or provided by the broadcaster or Webcaster. A buffering scheme may be employed to inherently adjust asynchronicity between a broadcast or Webcast and a personalized mediacast. Actual insertion of replacement programming and non-programming content segments may occur upstream of a content consumer device or at the content consumer device.
Owner:WIDEORBIT LLC

Device For High Throughput Investigations Of Multi-Cellular Interactions

Provided herein are microfluidic devices that can be used as a 3D bioassay, e.g., for drug screening, personalized medicine, tissue engineering, wound healing, and other applications. The device has a series of channels {e.g., small fluid channels) in a small polymer block wherein one or more of the channels can be filled with a biologically relevant gel, such as collagen, which is held in place by posts. As shown herein, when the device is plated with cells such as endothelial cells, new blood vessels grow in the gel, which is thick enough for the cells to grow in three dimensions. Other channels, e.g., fluid channels, allow drugs or biological material to be exposed to the 3D cell growth. Cells, such as endothelial cells, can be cultured and observed as they grow on the surface of a 3D gel scaffold, where e.g., rates of angiogenesis can be measured, as well as intervascularization and extravascularization of cancerous cells.
Owner:THE GENERAL HOSPITAL CORP +3

Transcriptional regulatory elements of biological pathways tools, and methods

The present invention provides compositions, kits, assemblies, libraries, arrays, and high throughput methods for large scale structural and functional characterization of gene expression regulatory elements in a genome of an organism, especially in a human genome, that are part of a common pathway. In one aspect of the invention, an array of expression constructs is provided, each of the expression constructs comprising: a nucleic acid segment operably linked with a reporter sequence in an expression vector such that expression of the reporter sequence is under the transcriptional control of the nucleic acid segment. The present invention can have a wide variety of applications such as in personalized medicine, pharmacogenomics, and correlation of polymorphisms with phenotypic traits.
Owner:SWITCHGEAR GENOMICS

Direct application system and method for the delivery of bioactive compositions and formulations

The embodiments relate to improved skin quality, health and appearance using a new delivery method and certain bioactive compositions and formulations. The system incorporates microneedle delivery technology with unique compositions and formulations. Such development allows for the pursuit of personalized medicine, or treatment delivery that can expand to remote controlled environment, immediate compounding and ultimate personalization with a state of the art longitudinal data predictive analytics. Certain formulations described herein are unique, combinatory and synergistic. Secured by high-tech proprietary system, there are unlimited potentials using AQT technology including but not limited to 3-D printing of a biodegradable micro chips that can be delivered via injection, AQT or any other possible route.
Owner:AQUAVIT PHARMA

Telemarketing customer service system based on artificial intelligence and business operation mode

InactiveCN107330706ARealize precision marketingRealize intelligent dispatchBuying/selling/leasing transactionsSpeech recognitionPrecision marketingIntelligence analysis
The invention provides a telemarketing customer service system based on artificial intelligence and a business operation mode. According to records of various customer services and historical clients in a platform, a character model of every customer service and a character model of every historical client are generated based on emotion identification system. By adopting an artificial intelligence analysis technology, multidimensional analysis of every customer service, every task, and every client is carried out to generate the intelligent portrait of every customer service, the intelligent portrait of every task, and the intelligent portrait of every client are generated. The intelligent matching of the intelligent portrait of every customer service, the intelligent portrait of every task, and the intelligent portrait of every client is carried out according to a preset rule, and then a plurality of orders are generated, and accurate marketing among the customer services, the tasks, and the clients is realized, and therefore personalized service is provided for the clients. After the orders are finished, the intelligent vouching of the finished orders by adopting a speech recognition system and a preset vouching strategy, real-time quality inspection and real-time billing are realized, and finally, work load of workers is effectively reduced, vouching time is shortened, and the accuracy of the quality inspection is improved.
Owner:SHANGHAI HANGDONG TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products